Medtronic

MDT

Market cap $135B

The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed the SPDR S&P 500 ETF (SPY) year-to-date, but November shows a reversal. Several Dividend Aristocrats, including CAH, CAT, CHRW, and ALB, have posted double-digit gains in 2025, while others lag behind. Dividend growth among Aristocrats averages 5.46% for 2025, with most constituents announcing increases, though growth is slightly below 2024 levels.

Medtronic Chairman and CEO Geoffrey Martha discusses the company's latest robotic innovation and how robotics can impact healthcare on 'The Claman Countdown.' #fox #media #us #usa #new #news #foxbusiness #medtronic #robotics #technology #healthcare #medical #innovation #science #global #economy #business #ai #future #engineering #automation #medicine #healthtech

The bull call spread takes advantage of low implied volatility for a bullish trade with less risk.

For investors, it's generally wise to buy and hold companies that continually raise their dividends. There are deals in energy, healthcare, consumer staples, and even the tech space.

Intuitive Surgical's robotics surge and Medtronic's broad innovation push set the stage for a high-tech showdown in next-gen minimally invasive care.

Medtronic not only performed better than expected in its most recent quarter, but also raised its guidance. The company's innovation is paying off, and will do so again as it launches new products.

Medtronic has increased its dividend payment for 48 consecutive years. The global healthcare technology company has a very healthy dividend.

Intuitive Surgical is the 800-pound gorilla in the robotic surgery space. Medtronic is entering the field and pays a solid dividend, too.

The recent high-velocity sell-off may be a preview of what's to come this year or in 2026.

Abbott and Medtronic are innovative healthcare leaders that generate consistent revenue and profits. They also have attractive long-term prospects and have consistently raised their dividend payouts.